In a study dissecting the clonal composition of CD8+ T cells in a metastatic melanoma patient undergoing pembrolizumab and brain RT, a proportion of tumor-enriched clonotypes were expanded in peripheral blood after RT [143]. The gene discussed is CD8A; the disease is metastatic melanoma.